| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.35 | 9e-12 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.23 | 5e-06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.097 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.094 | 0.09 |